ALK(002940.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
ALK
002940.SZ
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China.
2.805 T
002940.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking107/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.96%B
    • Profit Margin8.96%B
    • Gross Margin36.62%B
  • Growth ScoreC
    • Revenue YoY-2.15%D
    • Net Profit YoY86.98%A
    • Total Assets YoY6.75%B
    • Net Assets YoY4.76%C
  • Cash ScoreC
    • Cash Flow Margin156.94%B
    • OCF YoY-2.15%D
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreB
    • Gearing Ratio39.27%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

    Wallstreetcn·
    SZ
    159892
    -0.57%
    SH
    516820
    -1.20%
    SZ
    159849
    -1.05%
    Wallstreetcn·
    SZ
    159892
    -0.57%
    SH
    516820
    -1.20%
    SZ
    159849
    -1.05%

    A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit

    Zhitong·
    SZ
    300878
    +0.86%
    SZ
    300497
    -2.43%
    SZ
    002940
    -9.99%
    Zhitong·
    SZ
    300878
    +0.86%
    SZ
    300497
    -2.43%
    SZ
    002940
    -9.99%

    ALK: Starting in 2026, research and development investment will focus more on innovative drug projects

    Zhitong·
    SZ
    002940
    -9.99%
    Zhitong·
    SZ
    002940
    -9.99%

    ALK: Subsidiary obtains approval number for "Amoxicillin Clavulanate Potassium Tablets" veterinary drug product

    Zhitong·
    SZ
    002940
    -9.99%
    Zhitong·
    SZ
    002940
    -9.99%

    ALK released its performance for the first three quarters, with a net profit attributable to the parent company of 77.6899 million yuan, a year-on-year increase of 55.59%

    Zhitong·
    SZ
    002940
    -9.99%
    Zhitong·
    SZ
    002940
    -9.99%
    © 2026 Longbridge｜Disclaimer